Drugmakers Look to Limit Medicare’s New Power to Negotiate Lower Drug Prices
Drugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing...
Biotechnology Innovation Organization
WSJ News Exclusive | CEO of Biotech Lobbying Group BIO on Leave Amid Clash Over Direction
The chief executive of the biotechnology industry’s top lobbying group in Washington is on leave amid dissent within the organization...
